An Insmed takeout by Sanofi would be ‘clear strategic fit’ in respiratory space
If it came to fruition, the rumored deal between Sanofi and Insmed would likely be the year’s largest, with one analyst putting a potential value for the biotech as high as $40 billion.
comments(0)
5-min edit window · permanent after that